Astellas Pharma, Inc. (ALPMY)
14.67
+0.22
(+1.52%)
USD |
OTCM |
May 08, 16:00
Astellas Pharma Profit Margin (Quarterly) : 8.11% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc. | 18.75% |
| Takeda Pharmaceutical Co., Ltd. | 8.70% |
| Daiichi Sankyo Co., Ltd. | 15.52% |
| Eisai Co., Ltd. | 8.11% |
| Chugai Pharmaceutical Co., Ltd. | 35.87% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 17.94% |
| Return on Assets | 8.49% |
| Return on Invested Capital | 12.17% |
| Gross Profit Margin (Quarterly) | 75.94% |
| Operating Margin (Quarterly) | 14.47% |
| Return on Net Operating Assets | 10.37% |